综述PCT在不同感染性疾病中的临床应用情况(3)

　　4 总结。
　　
　　在众多感染和脓毒症诊断的生物标志物中，PCT是迄今为止应用最广泛的标志物。PCT能够帮助临床医生更早地鉴别细菌性感染，评估感染的严重程度并进行抗菌药物用药管理。但PCT与其他生物标志物一样，在应用时应结合患者病史，考虑到任何可能会干扰PCT检测结果的因素，考虑到其临床使用的局限性。同时，无论是PCT还是其他感染监测的指标，都远远不是一个“金标准”测试，目前以及将来需要更多的研究来确定其是否能对死亡率或并发症进行准确的预判，是否能安全、有效地指导抗菌药物管理。
　　
　　参考文献：
　　
　　[1] ASSICOT M,GENDREL D,CARSIN H,et al.High serum procalcitonin concentrations in patientswith sepsis and infection[J]. Lancet,1993,341（8844）：515-518.　　
　　[2] SCHUETZ P,ALBRICH W,MUELLER B.Procalcitonin for diagnosis of infection and guide toantibiotic decisions:past,present and future[J].BMC Med,2011,9:107.　　
　　[3] GILBERT D N. Use of plasma procalcitonin levelsas an adjunct to clinical microbiology[J]. J ClinMicrobiol,2010,48（7）：2325-2329.　　
　　[4] S E X T O N P M , C H R I S T O P O U L O S G ,CHRISTOPOULOS A,et al. Procalcitonin hasbioactivity at calcitonin receptor family complexes:potential mediator implications in sepsis[J]. Crit CareMed,2008,36（5）：1637-1640.　　
　　[5] LEE H. Procalcitonin as a biomarker of infectiousdiseases[J]. Korean J Intern Med,2013,28（3）：285-291.　　
　　[6] HOFFMANN G,TOTZKE G,SEIBEL M,et al. Invitro modulation of inducible nitric oxide synthasegene expression and nitric oxide synthesis byprocalcitonin[J]. Crit Care Med,2001,29（1）：112-116.　
　　[7] LINSCHEID P,SEBOEK D,SCHAER D J,et al.Expression and secretion of procalcitonin andcalcitonin gene-related peptide by adherent monocytesand by macrophage-activated adipocytes[J]. Crit CareMed,2004,32（8）：1715-1721.　　
　　[8] GOGOS C A,DROSOU E,BASSARIS H P,et al.2000,181（1）：176-180.　　
　　[9] LIMPER M,DE KRUIF M D,DUITS A J,et al. Thediagnostic role of procalcitonin and other biomarkersin discriminating infectious from non-infectiousfever[J]. J Infect,2010,60（6）：409-416.　　
　　[10] BECKER K L,NYL?N E S,WHITE J C,et al.Clinical review 167:procalcitonin and the calcitoningene family of peptides in inflammation,infection,and sepsis:a journey from calcitonin back to itsprecursors[J]. J Clin Endocrinol Metab,2004,89（4）：1512-1525.　　
　　[11] MULLER B,BECKER K L,SCHACHINGER H,et al.Calcitonin precursors are reliable markers of sepsisin a medical intensive care unit[J]. Crit Care Med,2000,28（4）：977-983.　　
　　[12] HARBARTH S,HOLECKOVA K,FROIDEVAUXC,et al. Diagnostic value of procalcitonin,interleukin-6,and interleukin-8 in critically illpatients admitted with suspected sepsis[J]. Am JRespir Crit Care Med,2001,164（3）：396-402.　　
　　[13] CHARLES P E,DALLE F,AHO S,et al. Serumprocalcitonin measurement contribution to the earlydiagnosis of candidemia in critically ill patients[J].Intensive Care Med,2006,32（10）：1577-1583.　　
　　[14] C H A L U PA P , B E R A N O , H E RWA L D H ,et al. Evaluation of potential biomarkers for thediscrimination of bacterial and viral infections[J].Infection,2011,39（5）：411-417.　　
　　[15] CUQUEMELLE E,SOULIS F,VILLERS D,et al. Can procalcitonin help identify associatedbacterial infection in patients with severe influenzapneumonia? A multicentre study[J]. Intensive CareMed,2011, 37（5）：796-800.　　
　　[16] REINHART K,BAUER M,RIEDEMANN N C,et al.New approaches to sepsis:molecular diagnosticsand biomarkers[J]. Clin Microbiol Rev, 2012,25（4）：609-634.　　
　　[17] SCHUETZ P,ALBRICH W,CHRIST-CRAINM,et al. Procalcitonin for guidance of antibiotictherapy[J]. Expert Rev Anti Infect Ther,2010,8（5）：575-587.　　
　　[18] MANIAN F A. Use of procalcitonin to guide durationof antimicrobial therapy in intensive care units:proceed with caution[J]. Clin Infect Dis,2012,54（4）：578.　　
　　[19] TANG B M,ESLICK G D,CRAIG J C,et al.Accuracy of procalcitonin for sepsis diagnosis in criticallyill patients: systematic review and meta-analysis[J].Lancet Infect Dis,2007,7（3）：210-217.　　
　　[20] UZZAN B,COHEN R,NICOLAS P,et al.Procalcitonin as a diagnostic test for sepsis in criticallyill adults and after surgery or trauma:a systematicreview and meta-analysis[J]. Crit Care Med,2006,34（7）：1996-2003.　　
　　[21] TSALIK E L,JAGGERS L B,GLICKMAN S W,et al. Discriminative value of inflammatory biomarkersfor suspected sepsis[J]. J Emerg Med,2012,43（1）：97-106.　　
　　[22] KOFOED K,ANDERSEN O,KRONBORG G,et al.Use of plasma C-reactive protein, procalcitonin,neutrophils,macrophage migration inhibitoryfactor,soluble urokinase-type plasminogen activatorreceptor,and soluble triggering receptor expressedon myeloid cells-1 in combination to diagnoseinfections:a prospective study[J]. Crit Care,2007,11（2）：R38.　
　　[23] HAEUSLER G M,CARLESSE F,PHILLIPS R S.An updated systematic review and meta-analysisof the predictive value of serum biomarkers in theassessment of fever during neutropenia in childrenwith cancer[J]. Pediatr Infect Dis J,2013,32（10）：e390-e396.　
　　[24] LYU Y X,YU X C,ZHU M Y. Comparison ofthe diagnostic value of procalcitonin and C-reactiveprotein after hematopoietic stem cell transplantation:a systematic review and meta-analysis[J]. TransplInfect Dis,2013,15（3）：290-299.　　
　　[25] O'GRADY N P,BARIE P S,BARTLETT J G,et al.Guidelines for evaluation of new fever in criticallyill adult patients:2008 update from the AmericanCollege of Critical Care Medicine and the InfectiousDiseases Society of America[J]. Crit Care Med,2008,36（4）：1330-1349.　　
　　[26] SIMON L,GAUVIN F,AMRE D K,et al. Serumprocalcitonin and C-reactive protein levels as markersof bacterial infection:a systematic review and meta-analysis[J]. Clin Infect Dis,2004,39（2）：206-217.　　
　　[27] JONES A E,FIECHTL J F,BROWN M D,et al.Procalcitonin test in the diagnosis of bacteremia:a meta-analysis[J]. Ann Emerg Med,2007,50（1）：34-41.　　
　　[28] UZZAN B,COHEN R,NICOLAS P,et al.Procalcitonin as a diagnostic test for sepsis in criticallyill adults and after surgery or trauma:a systematicreview and meta-analysis[J]. Crit Care Med,2006,34（7）：1996-2003.　　
　　[29] MOFIDI R,SUTTIE S A,PATIL P V,et al. Thevalue of procalcitonin at predicting the severityof acute pancreatitis and development of infectedpancreatic necrosis:systematic review[J]. Surgery,2009,146（1）：72-81.　　
　　[30] V O U L O U M A N O U E K , P L E S S A E ,KARAGEORGOPOULOS D E,et al. Serumprocalcitonin as a diagnostic marker for neonatalsepsis:a systematic review and meta-analysis[J].Intensive Care Med,2011,37（5）：747-762.　　
　　[31] M?LLER F,CHRIST-CRAIN M,BREGENZERT,et al. Procalcitonin levels predict bacteremia inpatients with community-acquired pneumonia:a prospective cohort trial[J]. Chest,2010,138（1）：121-129.　　
　　[32] VAN NIEUWKOOP C,BONTEN T N,VAN'TWOUT J W,et al. Procalcitonin reflects bacteremiaand bacterial load in urosepsis syndrome:aprospective observational study[J]. Crit Care,2010,14（6）：R206.　　
　　[33] SAKR Y,SPONHOLZ C,TUCHE F,et al. Therole of procalcitonin in febrile neutropenic patients:review of the literature[J]. Infection,2008,36（5）：396-407.　　
　　[34] LIN S G,HOU T Y,HUANG D H,et al. Roleof procalcitonin in the diagnosis of severe infectionin pediatric patients with fever and neutropenia-asystemic review and meta-analysis[J]. Pediatr InfectDis J,2012,31（10）：e182-e188.　　
　　[35] LIN K H,WANG F L,WU M S,et al. Serumprocalcitonin and C-reactive protein levels as markersof bacterial infection in patients with liver cirrhosis:a systematic review and meta-analysis[J]. DiagnMicrobiol Infect Dis,2014,80（1）：72-78.　　
　　[36] HUSOVAL,HUSA P,SENKYRIK M,et al.Procalcitonin as an indicator of infection in patientswith liver cirrhosis[J]. Vnitr Lek,2004,50（2）：153-156.　　
　　[37] ENGLAND J T,DEL VECCHIO M T,ARONOFFS C. Use of serum procalcitonin in evaluation offebrile infants:a meta-analysis of 2 317 patients[J]. JEmerg Med,2014,47（6）：682-688.　　
　　[38] MARIN REINA P,RUIZ ALC?NTARA I,VIDALMIC? S,et al. Accuracy of the procalcitonin test inthe diagnosis of occult bacteremia in paediatrics:a systematic review and meta-analysis[J]. An Pediatr（Barc），2010,72（6）：403-412.　　
　　[39] RADIMERSKI T M,GRISOUARD J,TIMPER K,et al. Role of calcium in lipopolysaccharide-inducedcalcitonin gene expression in human adipocytes[J].Innate Immun,2011,17（4）：403-413.　　
　　[40] DE KRUIF M D,LEMAIRE L C,GIEBELENI A,et al. The influence of corticosteroids on therelease of novel biomarkers in human endotoxemia[J].Intensive Care Med,2008,34（3）：518-522.　　
　　[41] REINHART K,MEISNER M. Biomarkers in thecritically ill patient:procalcitonin[J]. Crit CareClin,2011,27（2）：253-263.　　
　　[42] DELLINGER R P,LEVY M M,CARLET J M,et al. Surviving sepsis campaign:internationalguidelines for management of severe sepsis and septicshock:2008[J]. Intensive Care Med,2008,34（1）：17-60.　　
　　[43] SCHUETZ P,CHIAPPA V,BRIEL M,et al.Procalcitonin algorithms for antibiotic therapydecisions:a systematic review of randomizedcontrolled trials and recommendations for clinicalalgorithms[J]. Arch Intern Med,2011,171（15）：1322-1331.　
　　[44] KOPTERIDES P,SIEMPOS I I,TSANGARIS I,et al. Procalcitonin-guided algorithms of antibiotictherapy in the intensive care unit:a systematic reviewand meta-analysis of randomized controlled trials[J].Crit Care Med,2010,38（11）：2229-2241.　　
　　[45] SCHUETZ P,M?LLER B,CHRIST-CRAIN M,et al. Procalcitonin to initiate or discontinue antibioticsin acute respiratory tract infections[J]. Evid BasedChild Health,2013,8（4）：1297-1371.　　
　　[46] BECKERKL,SNIDERR ,NYLENES .Procalcitonin assay in systemic inflammation,infection,and sepsis:clinical utility and limitations[J].Crit Care Med,2008,36（3）：941-952.　　
　　[47] AABENHUS R,JENSEN JU. Procalcitonin-guidedantibiotic treatment of respiratory tract infections ina primary care setting:are we there yet?[J]. PrimCare Respir J,2011,20（4）：360-367.　
　　[48] 冯仁丰 . 降钙素原的标准化 [ J ] . 临床实验室，2014,8（10）：46-47.Pro-versus anti-inflammatory cytokine profile inpatients with severe sepsis:a marker for prognosisand future therapeutic options[J]. J Infect Dis,